Toggle navigation
Who We Are
Company Overview
Management
Geographical Map
Disease & Therapeutics
TGF-¥â in Fibrosis
IBD
Eye Disease
Adhesion
NASH
IPF
Healthy Aging & Longevity
R&D Pipeline
Pipeline
Publications & Patents
Communication
Notice
News
Careers
Investors & Partners
1:1 Inquiries
Ask and Answer
FAQ
Toggle navigation
Who We Are
Company Overview
Management
Geographical Map
Disease & Therapeutics
TGF-¥â in Fibrosis
IBD
Eye Disease
Adhesion
NASH
IPF
Healthy Aging & Longevity
R&D Pipeline
Pipeline
Publications & Patents
Communication
Notice
News
Careers
Investors & Partners
1:1 Inquiries
Ask and Answer
FAQ
EWHA DrugDesignHouse
Novel molecules for unmet needs
EWHA
Anti-fibrotic and longevity medicine
DrugDesignHouse
Vactosertib, a first-in-class ALK5 inhibitor
Company
Brief overview of our company that has dedicated to research and develop with our vision to novel drug.
Disease & Therapeutics
We have organized our business details and future projects.
Pipeline
Get a closer look at our developting agents to improve the cure.
Communication
It's a space where you can see our activities and notices to share with the media.
Notice
More
Contact Us
We will kindly reply if you leave any questions.
Geographical Map
It's a place where you can reach our company.
Contact Us
Tel (82)2 3277 3025
Fax (82)2 3277 2467
E-Mail, info@ewhaddh.com
We're closed on Saturdays/Sundays/Holidays.